- Home
- ELEV vs BEEM Comparison
ELEV vs BEEM Comparison
Compare ELEV & BEEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELEV
- BEEM
- Stock Information
- Founded
- ELEV 2019
- BEEM 2006
- Country
- ELEV United States
- BEEM United States
- Employees
- ELEV N/A
- BEEM N/A
- Industry
- ELEV Biotechnology: Pharmaceutical Preparations
- BEEM Semiconductors
- Sector
- ELEV Health Care
- BEEM Technology
- Exchange
- ELEV Nasdaq
- BEEM Nasdaq
- Market Cap
- ELEV 22.8M
- BEEM 23.4M
- IPO Year
- ELEV 2021
- BEEM N/A
- Fundamental
- Price
- ELEV $0.38
- BEEM $1.61
- Analyst Decision
- ELEV Hold
- BEEM Strong Buy
- Analyst Count
- ELEV 6
- BEEM 4
- Target Price
- ELEV $1.77
- BEEM $5.33
- AVG Volume (30 Days)
- ELEV 2.0M
- BEEM 1.2M
- Earning Date
- ELEV 08-05-2025
- BEEM 08-12-2025
- Dividend Yield
- ELEV N/A
- BEEM N/A
- EPS Growth
- ELEV N/A
- BEEM N/A
- EPS
- ELEV N/A
- BEEM N/A
- Revenue
- ELEV N/A
- BEEM $41,099,000.00
- Revenue This Year
- ELEV N/A
- BEEM N/A
- Revenue Next Year
- ELEV N/A
- BEEM $38.51
- P/E Ratio
- ELEV N/A
- BEEM N/A
- Revenue Growth
- ELEV N/A
- BEEM N/A
- 52 Week Low
- ELEV $0.22
- BEEM $1.33
- 52 Week High
- ELEV $3.28
- BEEM $7.68
- Technical
- Relative Strength Index (RSI)
- ELEV 62.35
- BEEM 60.58
- Support Level
- ELEV $0.38
- BEEM $1.39
- Resistance Level
- ELEV $0.39
- BEEM $1.56
- Average True Range (ATR)
- ELEV 0.01
- BEEM 0.10
- MACD
- ELEV 0.00
- BEEM 0.02
- Stochastic Oscillator
- ELEV 85.00
- BEEM 81.09
About ELEV Elevation Oncology Inc. Common stock
Elevation Oncology Inc is an oncology company focused on the development of selective cancer therapies to treat patients across a range of solid tumors with unmet medical needs. Its product candidate, EO-3021 (also known as SYSA1801 or CPO102), is an ADC comprised of a fully human anti-Claudin 18.2 immunoglobulin G1 (IgG1) monoclonal antibody (mAb) site-specifically conjugated with a cleavable linker to the cytotoxic monomethyl auristatin E (MMAE) payload. Claudin 18.2 is overexpressed in several types of cancers, including gastric, esophageal, pancreatic, ovarian and lungon.
About BEEM Beam Global
Beam Global produces sustainable technology for electric vehicle (EV) charging, outdoor media, and energy security, without the construction, disruption, and costs of grid-tied solutions. Its products are founded upon its patented EV ARC and Solar Treelines and include BeamTrak patented solar tracking, and ARC Technology energy storage, along with EV charging, outdoor media, and disaster preparedness packages. From start to finish, the company develops, patents, designs, engineers, and manufactures renewably energized products that help the environment, empower communities, and keep people moving.